null

SARS-CoV-2 RBD of Spike protein GH452R.V1, CAL.20C, L452R – lineage B.1.429 – CAL Variant

(No reviews yet) Write a Review
SKU:
CoV-CAL
€185.00 - €320.00
Frequently bought together:

Description

A new emerging variant of SARS-CoV-2, named CAL.20C or lineage B.1.429, was recently reported in California (US). Identified by researchers at Cedars-Sinai Medical Center in July 2020, the variant was initially reported as rare only to resurface later that year (October). The most recent reports indicate CAL.20C is swiftly replacing the former lineage 20G – the dominant variant of the region until then.
Unpublished data suggest this variant may account for almost half of the virus genome samples collected in the Los Angeles region alone throughout January 2021. Moreover, scientists suspect this lineage to be responsible for a resurgence of cases. The new strain is characterized by multiple mutations on the spike protein. Although the impact of these mutations on human-to-human transmissibility and disease severity is yet unknown, experts have urged international authorities to keep a close track of its spread.
CAL.20C is characterized by the presence of five non-synonymous amino acid changes: one observed within the receptor-binding domain (RBD) – L452R; two other mutations detected outside the RBD – S13I and W152; and the remaining mutations in ORF1ab (I4205V and B1183Y). So far, the strain has only shown a sustained spread in California (primarily in Southern California), with only a few genomes reported in Australia, New Zealand, and the UK.
Mutation L452R in the RBD is particularly worrisome due to being located in a key amino acid residue. Although it was still not proved this mutation has an impact in affinity to the human ACE2, it has already been shown that it makes the virus more resistant to some neutralizing monoclonal antibodies. Thus, it is highly likely that the L452R amino acid change enhances SARS-CoV-2’s ability to evade the human immune response. At the moment, the impact of this mutation on vaccine efficacy is currently being investigated.

Product name SARS-CoV-2 RBD of Spike protein, GH452R.V1, CAL.20C, L452R – lineage B.1.429 – CAL Variant
Origin species SARS-COV2
Expression system Eukaryotic expression
Buffer PBS, pH7.8
Delivery condition Dry Ice
Storage condition 4°C for short term; -20°c or -80°C for long term
Brand ProteoGenix
Host species Mammalian cells
Fragment Type Spike protein fragment
Aliases /Synonyms lineage B.1.429, CAL.20C, Californian variant, CAL variant
Reference PX-COV-P055
Note For research use only

 

View AllClose